Correlation Between Agilent Technologies and Alx Oncology
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and Alx Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and Alx Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and Alx Oncology Holdings, you can compare the effects of market volatilities on Agilent Technologies and Alx Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of Alx Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and Alx Oncology.
Diversification Opportunities for Agilent Technologies and Alx Oncology
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Agilent and Alx is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and Alx Oncology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alx Oncology Holdings and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with Alx Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alx Oncology Holdings has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and Alx Oncology go up and down completely randomly.
Pair Corralation between Agilent Technologies and Alx Oncology
Taking into account the 90-day investment horizon Agilent Technologies is expected to under-perform the Alx Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Agilent Technologies is 3.78 times less risky than Alx Oncology. The stock trades about -0.02 of its potential returns per unit of risk. The Alx Oncology Holdings is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 181.00 in Alx Oncology Holdings on September 25, 2024 and sell it today you would lose (19.00) from holding Alx Oncology Holdings or give up 10.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Agilent Technologies vs. Alx Oncology Holdings
Performance |
Timeline |
Agilent Technologies |
Alx Oncology Holdings |
Agilent Technologies and Alx Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Agilent Technologies and Alx Oncology
The main advantage of trading using opposite Agilent Technologies and Alx Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, Alx Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will offset losses from the drop in Alx Oncology's long position.Agilent Technologies vs. Twist Bioscience Corp | Agilent Technologies vs. Natera Inc | Agilent Technologies vs. Guardant Health | Agilent Technologies vs. Castle Biosciences |
Alx Oncology vs. Cabaletta Bio | Alx Oncology vs. Viracta Therapeutics | Alx Oncology vs. Eyepoint Pharmaceuticals | Alx Oncology vs. Biomea Fusion |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |